Decreased Frontal Gamma Activity in Alzheimer Disease Patients.

Publication Year: 2022

DOI:
10.1002/ana.26444

PMCID:
PMC9543336

PMID:
35713198

Journal Information

Full Title: Ann Neurol

Abbreviation: Ann Neurol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Potential Conflicts of Interest GK and AM hold patents submitted on precision meuromodulation in patients with Alzheimer's disease partially including the methodology described in the current work."

Evidence found in paper:

"We thank all the patients who took part in this study and their families. This study was partially supported by grants to G.K. from the BrightFocus Foundation, the Alzheimer's Drug Discovery Foundation, The European Union program Horizon 2020 (Neurotwin) and the Italian Ministry of Health. E.P.C. received “Be‐for‐ERC” funding from La Sapienza University."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025